Method of, apparatus and graphical user interface for automatic diagnostics
    2.
    发明授权
    Method of, apparatus and graphical user interface for automatic diagnostics 有权
    用于自动诊断的方法,装置和图形用户界面

    公开(公告)号:US07246273B2

    公开(公告)日:2007-07-17

    申请号:US10639061

    申请日:2003-08-11

    IPC分类号: G06F11/00

    CPC分类号: G06F11/2635

    摘要: The present invention includes a method, apparatus and graphical user interface (GUI) that allows a simple, precise, thorough, automatic and interactive diagnostic system for electronic devices. The present invention fully automates every test item, as a memory device including the diagnostic test items is inserted into the electronic device and is configured to automatically begin the diagnostic method. The present invention allows for interactive diagnostic analysis and a user is able to automatically repair many of the defects detected by the diagnostic method.

    摘要翻译: 本发明包括允许用于电子设备的简单,精确,彻底,自动和交互式诊断系统的方法,装置和图形用户界面(GUI)。 本发明将每个测试项目完全自动化,作为包括将诊断测试项目插入到电子设备中并被配置为自动开始诊断方法的存储设备。 本发明允许交互式诊断分析,并且用户能够自动修复由诊断方法检测到的许多缺陷。

    Sidespray having volume control
    3.
    发明授权
    Sidespray having volume control 有权
    Sidespray具有音量控制

    公开(公告)号:US08783288B2

    公开(公告)日:2014-07-22

    申请号:US12911795

    申请日:2010-10-26

    申请人: James Lin

    发明人: James Lin

    IPC分类号: F16K11/20 F16K47/08 B05B1/30

    摘要: A sidespray for use with a water faucet unit includes a trigger valve and a volume control valve. The trigger valve is configured to define a full-ON water flow condition and a full-OFF water flow condition for the sidespray. A diverter actuator is coupled to the trigger valve to select between the full-ON water flow condition and the full-OFF water flow condition for the sidespray. The volume control valve is configured to define a volume-variable water passageway to limit a water flow volume through the sidespray when the trigger valve has set the sidespray to the full-ON water flow condition. A volume control actuator is coupled to the volume control valve to selectively adjust the water flow volume through the sidespray.

    摘要翻译: 与水龙头单元一起使用的侧喷包括触发阀和容积控制阀。 触发阀被配置为为侧喷液体定义全开水流条件和全关水流量条件。 分流器致动器联接到触发阀以在全开水流条件和侧喷面的全关水流条件之间进行选择。 体积控制阀构造成限定一个体积可变的水通道,以在触发阀将侧面喷雾设定到全开水流状态时限制通过侧面喷雾的水流量。 音量控制致动器耦合到音量控制阀以选择性地调节通过侧面喷射的水流量。

    SOCIALLY-AUTHORED CONTEXT-INITIATED PROCESSES
    5.
    发明申请
    SOCIALLY-AUTHORED CONTEXT-INITIATED PROCESSES 审中-公开
    社会上授权的上下文过程

    公开(公告)号:US20090193339A1

    公开(公告)日:2009-07-30

    申请号:US12021783

    申请日:2008-01-29

    IPC分类号: G06F9/44 G06F3/048

    CPC分类号: G06F9/453

    摘要: Embodiments herein provide a method that maintains computerized scripts. The scripts provide assistance to users with respect to using at least one computer software application that is operating on a computerized device. The method receives, from the user, at least one trigger. This process creates or “authors” the trigger. This “trigger” is an item that automatically initiates at least one of the scripts for the user. In addition, the method adds the trigger to the computer software application (not automatically, but instead based on user input). Thus, when initiated by the trigger, the script automatically outputs assistance (text, sounds, illustrations, educational videos, etc.) to the user through the computerized interface of the computerized device, so as to provide the needed assistance to the user.

    摘要翻译: 本文的实施例提供了一种维护计算机化脚本的方法。 这些脚本向用户提供关于使用在计算机化设备上运行的至少一个计算机软件应用程序的帮助。 该方法从用户接收至少一个触发器。 此过程创建或“作者”触发器。 此“触发器”是自动启动用户至少一个脚本的项目。 此外,该方法将触发器添加到计算机软件应用程序(不是自动的,而是基于用户输入)。 因此,当由触发器发起时,脚本通过计算机化设备的计算机化界面自动地向用户输出辅助(文本,声音,插图,教育视频等),以便向用户提供所需的帮助。

    BENZOTHIAZOLE AND AZABENZOTHIAZOLE COMPOUNDS USEFUL AS KINASE INHIBITORS
    6.
    发明申请
    BENZOTHIAZOLE AND AZABENZOTHIAZOLE COMPOUNDS USEFUL AS KINASE INHIBITORS 有权
    苯并噻唑和亚苄基唑类化合物作为激酶抑制剂有用

    公开(公告)号:US20090118272A1

    公开(公告)日:2009-05-07

    申请号:US12333425

    申请日:2008-12-12

    CPC分类号: C07D513/04 C07D417/04

    摘要: A compound of Formula (I) an enantiomer, diastereomer or a pharmaceutically-acceptable salt thereof, wherein A is independently selected from: further wherein R1, R2, R3, R4, R5, R6, R7, and W are as described herein.Also disclosed is a compound of Formula (II) an enantiomer, diastereomer, or a pharmaceutically-acceptable salt thereof, wherein each of G, X and Y are independently CH or N, wherein at each occurrence at least one of G, X or Y is N and the other two of G, X or Y are CH; and B is independently selected from: further wherein R1, R2, R3, R4, R5, R8, R9 and Z are as described herein.Also disclosed are pharmaceutical compositions containing compounds of Formula (I) and Formula (II), and methods of treating conditions associated with the activity of p38 kinase.

    摘要翻译: 式(I)化合物,其对映异构体,非对映体或其药学上可接受的盐,其中A独立地选自:其中R 1,R 2,R 3,R 4,R 5,R 6,R 7和W如本文所述。 还公开了式(II)的化合物,其对映异构体,非对映异构体或其药学上可接受的盐,其中G,X和Y各自独立地为CH或N,其中在每次出现时,G,X或Y中的至少一个 是N,另外两个G,X或Y是CH; 并且B独立地选自:其中R 1,R 2,R 3,R 4,R 5,R 8,R 9和Z如本文所述。 还公开了含有式(I)和式(II)化合物的药物组合物,以及治疗与p38激酶活性相关的病症的方法。

    Benzothiazole and azabenzothiazole compounds useful as kinase inhibitors
    7.
    发明授权
    Benzothiazole and azabenzothiazole compounds useful as kinase inhibitors 有权
    可用作激酶抑制剂的苯并噻唑和氮杂苯并噻唑化合物

    公开(公告)号:US07473784B2

    公开(公告)日:2009-01-06

    申请号:US11494234

    申请日:2006-07-27

    IPC分类号: A61K31/428 C07D417/04

    CPC分类号: C07D513/04 C07D417/04

    摘要: A compound of Formula (I) an enantiomer, diastereomer or a pharmaceutically-acceptable salt thereof, wherein A is as described herein. Also disclosed is a compound of Formula (II) an enantiomer, diastereomer, or a pharmaceutically-acceptable salt thereof, wherein each of G, X and Y are independently CH or N, wherein at each occurrence at least one of G, X or Y is N and the other two of G, X or Y are CH; and B, R1, R2, R3, R4, R5, R8, R9 and Z are as described herein. Also disclosed are pharmaceutical compositions containing compounds of Formula (I) and Formula (II), and methods of treating conditions associated with the activity of p38 kinase.

    摘要翻译: 式(I)的化合物,其对映体,非对映异构体或其药学上可接受的盐,其中A如本文所述。 还公开了式(II)的化合物,其对映异构体,非对映异构体或其药学上可接受的盐,其中G,X和Y各自独立地为CH或N,其中在每次出现时,G,X或Y中的至少一个 是N,另外两个G,X或Y是CH; 并且B,R 1,R 2,R 3,R 4,R 5,R 8,R 9和Z如本文所述。 还公开了含有式(I)和式(II)化合物的药物组合物,以及治疗与p38激酶活性相关的病症的方法。